Global Biosimilars Market Value Could Hit $55 Billion by 2020, Finds New Report
The global biosimilars market value is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, with growth primarily driven by a promising pipeline in active development and government efforts to reduce healthcare spending, according to business intelligence provider Publisher.
View full press release